Urology Times is the leader in clinical analysis and perspective for practicing urologists. But now, we have more content tailored to residents than ever. Take the next step and join our Program Director Panel to help us shape content for young doctors.
Study identifies 11 gene mutations linked to aggressive prostate cancer
October 3rd 2023This is the largest prostate cancer study that examined the exome, according to the researchers, who believe their findings can potentially inform the makeup of panels used for genetic testing in prostate cancer.
Dr. Schuster highlights the FDA approval of imaging agent flotufolastat F 18 in prostate cancer
June 22nd 2023"We're excited that the FDA approval of this radiotracer gives us yet more tools at our disposal to diagnose prostate cancer in all its forms, from early to late in the disease process," says David M. Schuster, MD, FACR.
2 Clarke Drive
Cranbury, NJ 08512